Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 31Colorectal Neoplasms 12Pancreatic Neoplasms 11Carcinoma, Hepatocellular 11Stomach Neoplasms 8Neoplasms 7Liver Neoplasms 7Esophageal Neoplasms 6Carcinoma, Renal Cell 6Neoplasm Metastasis 5Gastrointestinal Neoplasms 5Adenoma, Islet Cell 5Neuroendocrine Tumors 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Prostatic Neoplasms 3Carcinoma 3Thyroid Neoplasms 2Sarcoma 2Rectal Neoplasms 2Neoplasms, Glandular and Epithelial 2Neoplasms by Site 2Neoplasms by Histologic Type 2Multiple Myeloma 2Lung Neoplasms 2Hematologic Neoplasms 2Digestive System Neoplasms 2Colonic Neoplasms 2Adenoma 2Adenocarcinoma Of Esophagus 2

Interventions

apatinib 9Paclitaxel 9Capecitabine 7Oxaliplatin 6camrelizumab 5Cisplatin 5S 1 (combination) 4Fluorouracil 3Docetaxel 3130-nm albumin-bound paclitaxel 3titanium silicide 2Leucovorin 2Drug Therapy 2vorolanib 1trifluridine tipiracil drug combination 1tipiracil 1spartalizumab 1rucaparib 1relatlimab 1raltitrexed 1pazopanib 1olaparib 1lobaplatin 1linrodostat 1ezogabine 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1Trifluridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Gastric Cancer × Sunitinib × Gastrointestinal × Clear all
NCT01238055 2013-04-09

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

Samsung Medical Center

Phase 2 Completed
116 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡